Shares of Cardio Diagnostics Holdings, Inc. (CDIO), an artificial intelligence-powered precision cardiovascular medicine company, are rising nearly 150% Tuesday morning following the launch of PrecisionCHD, a blood test for the early detection of coronary heart disease.
PrecisionCHD, a non-invasive test detects coronary heart disease with better than 75% sensitivity in both men and women. the company said.
CDIO is at $3.15 currently. It has traded in the range of $0.79-$10.25 in the last 1 year.
Source: Read Full Article
Lates News:
-
Pundit Who Predicted Bitcoin's Plunge To $20k Lowers Bet To $12,000
-
Huadi International Rises Following Deal With China Huanqiu
-
Bloomberg Expert Analyst Explains Why A Fall To $10,000 Isn’t Bad For Bitcoin
-
Woman Targets Husband's Bitcoin in Novel Divorce Proceedings
-
Tesla Sells 75% of Its Bitcoin (Because of COVID Lockdowns) but None of Its Dogecoin